Treat Lupus Safely and More Effectively
www.universitytech.io
Treat Lupus Safely and More Effectively
New Targeting Strategy for Lupus Erythematosus
Tags: University of Melbourne, Australia, Healthcare & Lifesciences
This novel therapy targets autoimmunity in lupus without harming B-cells. It offers a unique approach by selectively removing an inflammatory component, improving upon current treatments that can weaken the immune system. With lupus affecting over five million globally, this innovation could provide a more effective, safer option. Additionally, a biomarker for patient stratification enhances clinical trial targeting. This represents a significant advance in lupus treatment, promising better outcomes for patients.
IP Type or Form Factor: Discovery & Research; Platform
TRL: 3 - proof of concept with needs validated
Industry or Tech Area: Biotechnology; Pharmaceutical Engineering
